chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient stated that "seconds after getting vaccine she was extremely dizzy, heart pounding, nauseated, had a icy hot surge from head to feet, and was shaking." Patient states these symptoms lasted for "12 hours and she now feels fine."
Information has been received from a consumer concerning her almost 3-year-old son with no pertinent medical history or allergies, who at about 18 months of age, in approximately February 2005, was vaccinated with a dose of Varivax. Concomitant therapy included an "antiviral" (unspecified). The patient showed signs of a rash on the back of the thighs and back medial attention was sought and he was diagnosed with shingles on 01-AUG-2006. The pediatric office then noted that the vaccination given to the patient "may have been outside the recommended storage ranges and may not have been viable". At the time of the report the patient had not recovered from the shingles. No further information was available regarding the temperature excursion. No product quality complaint was involved.
LOCALIZED SWELLING (KNOT) FORMED AT INJECTION SITE ON LEFT ARM. COLD COMPRESS WAS APPLIED FOR APPROX 15 MINUTES. PATIENT WAS FEELING FINE (NO PAIN, DIZZINESS, OR ANY OTHER COMPLAINTS) AND IS TO FOLLOW UP WITH HER DOCTOR AND THE PHARMACY IF ANY OTHER REACTION OCCURS.
Pt reports first felt like a "BB" under the skin after vaccination,  but grew over time with concern for a pustular head emerging. Saw PCP in March 2023, was put on Clindamycin and mupirocin ointment. May 2023, had drainage now with appearance of a cap hemangioma to area and a dimple to skin so was referred to Dermatology. Saw Derm and diagnosed with atropic scar with lipoatrophy right anterior proximal thigh.
First inject lot # ej1685  in right arm.  had itchy rash with open wounds all over right breast with burning pain.  Was told is was shingles but wasn?t treated. Was told to get the second vaccine in the opposite arm to see if the same thing happens.  Received 2nd injection in left arm and ended up with full blown symptoms of COVID.  Uncontrollable shakes, cold, fever, severe body aches, cough, diarrhea and the rash still remains.  As of today, I have an upper respiratory infection as well as the open rash, which the PCP listed has taken control of and deemed the cause side effects of the second injection.
This spontaneous report as received from a nurse practitioner refers to a 52 year old female via a company representative. Patient's medical history, concurrent conditions and drug reactions/allergies were not reported. On an unknown date, the patient was vaccinated with a dose of VARIVAX (lot#, expiration date, strength, dose and route of administration were not reported). Patient's concomitant medication was not provided. On an unknown date, within 12 days after receipt of the vaccine, the patient experienced a "varicella like rash" at the injection site. On 15-SEP-2016, the patient was seen in the office and the previously reported "varicella like rash" was diagnosed as chickenpox (varicella) and was found to be more widespread. At the reporting time, the outcome of varicella was unknown. The reporter did not provide the relationship between varicella and VARIVAX. A product quality complaint was not involved. Additional information has been requested.
Immediately post vax, the pt began crying and did not stop for several hours, and could not be consoled. He cried very hard most of that evening, off and on all night, and most of the next day. Tylenol was given and seemed to help a little. Mom says pt felt a little warm, but she did not take his temperature. He also ate poorly.
It was very itchy; he developed a symmetrical morbilliform pink skin rash in his lateral flank that irradiated to his chest; symmetrical morbilliform pink skin rash; He was also feeling warm; This non-serious case was reported by a physician via call center representative and described the occurrence of feeling of warmth in a 71-year-old male patient who received RSVPreF3 adjuvanted (Arexvy) (batch number GX45D, expiry date 19-OCT-2024) for prophylaxis.   On 07-AUG-2023, the patient received Arexvy (left arm). On 07-AUG-2023, 2 hrs after receiving Arexvy, the patient experienced itchy rash (Verbatim: It was very itchy), rash (Verbatim: he developed a symmetrical morbilliform pink skin rash in his lateral flank that irradiated to his chest) and morbilliform rash (Verbatim: symmetrical morbilliform pink skin rash). In AUG-2023, the patient experienced feeling of warmth (Verbatim: He was also feeling warm). The patient was treated with antihistamine (Antihistamines). The outcome of the feeling of warmth, itchy rash, rash and morbilliform rash were resolving.   It was unknown if the reporter considered the feeling of warmth, itchy rash, rash and morbilliform rash to be related to Arexvy.     It was unknown if the company considered the feeling of warmth, itchy rash, rash and morbilliform rash to be related to Arexvy.   Additional Information: Receipt date: 9-AUG-2023 The reporter was a physician who received the Arexvy vaccine at 2:30PM in his left arm. According to reporter, 2 and a half hours later he developed a symmetrical morbilliform pink skin rash in his lateral flank that irradiated to his chest and upper left arm a day after. It was very itchy. Reporter states he used antihistamines 3 doses and dry powder to reduce the itchiness. No blisters, no vesicles or anaphylaxis reported. The reporter was also feeling warm. The symptoms persisted until the time of this report but its decreasing. Reporter states he was in good health, not medical conditions to report. Consented to follow up.
I do not know if this was related to the vaccine but I have never had anything like this happen in the past.  I started having discomfort on May 8, 2021 in the area of my right elbow but it progressed to pain and swelling. I was hospitalized for four days from May 20, 2021 through May 23, 2021 and had surgery on my right elbow due to an infected blood clot.   After surgery, I was treated with Cephalexin (500mg) to treat the Strep infection.
itchy rash on neck; Varicella like rash; This case was reported by a pharmacist via call center representative and described the occurrence of itchy rash in a 76-year-old female patient who received Herpes zoster (Shingrix) (batch number M9P52, expiry date 18th December 2021) for prophylaxis.   On 8th November 2019, the patient received the 1st dose of Shingrix. On 10th November 2019, 2 days after receiving Shingrix, the patient experienced itchy rash and varicella-like rash. On an unknown date, the outcome of the itchy rash and varicella-like rash were unknown.   It was unknown if the reporter considered the itchy rash and varicella-like rash to be related to Shingrix.  Additional details were provided as follows: The pharmacist reported that the patient received 1st dose of Shingrix vaccine and developed itchy rash behind her neck. The rash was approximately 2 inch circle, appeared like shingles with no blisters. The reporter consented to follow up.
Flu-like symptoms (coughing hard), injection site. (One arm for both vaccines) was sore for 3 days. Finished 3 packs of cough drops and 3 boxes DAYQUIL for a span of 4-5 days.
I was a totally different person; Could not move; Weak; Very tired; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (I was a totally different person), MOBILITY DECREASED (Could not move), ASTHENIA (Weak) and FATIGUE (Very tired) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Type 1 diabetes mellitus.    On 01-Sep-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Sep-2021, the patient experienced FEELING ABNORMAL (I was a totally different person), MOBILITY DECREASED (Could not move), ASTHENIA (Weak) and FATIGUE (Very tired). At the time of the report, FEELING ABNORMAL (I was a totally different person), MOBILITY DECREASED (Could not move), ASTHENIA (Weak) and FATIGUE (Very tired) outcome was unknown.            Concomitant medication of the patient was not reported.  The patient did not took any medications or treatment.   Most recent FOLLOW-UP information incorporated above includes: On 07-Sep-2021: Follow-up information received on 07-Sep-2021; included no new information.
Patient received vaccine on 7/23/2021. Side effects started 8/3/21: infection, nerve pain. She felt like someone hit her bone after vaccination. Looking at the pictures dated of shoulder, the infection was located above the shoulder. She was hospitalized and needed surgery on shoulder. Doctor gave her antibiotics.
Patient states he had the COVID-19 vaccination in Feb 2021 and tested positive for COVID-19 on 8/23/2021.
receiving dose from an expired Moderna COVID19 vaccine vial; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (receiving dose from an expired Moderna COVID19 vaccine vial) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (receiving dose from an expired Moderna COVID19 vaccine vial). On 04-Oct-2021, EXPIRED PRODUCT ADMINISTERED (receiving dose from an expired Moderna COVID19 vaccine vial) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   No concomitants and treatment drugs were provided.
This spontaneous report was received from a registered nurse via physician and medical assistant regarding a patient of unknown age and gender. The patient's medical history, current conditions and concomitant medications were not reported. On an unknown date, the patient was vaccinated with improperly stored dose of ROTATEQ lot # M035456 with expiry date 01-MAY-2018, (strength, dose and route of administration were not reported) for prophylaxis. The vaccine was exposed to 31 Fahrenheit degree (F) or colder (25F) for 1 hour 53 minutes and 47 Fahrenheit degree (F) to 77 Fahrenheit degree (F) (49F) for 3 hours 59 minutes. There was no previous temperature excursion. Digital data logger was involved. No adverse effects reported. There was no product quality complaint (PQC) involved. This is one of the several reports received from same reporter.; Sender's Comments:  US-009507513-1708USA003308: US-009507513-1709USA011732: US-009507513-1709USA011733: US-009507513-1709USA011734: US-009507513-1709USA011735: US-009507513-1709USA011736: US-009507513-1709USA011737: US-009507513-1708USA003070:
CHIEF COMPLAINT:   Pt. arrives from home in a POV with cough, SOB at rest, temperature, and fatigue. Pt. was diagnosed with Covid on Friday 12/10/21, and today feels much worse.   HISTORY OF PRESENT ILLNESS:     47-year-old female presenting to the emergency room cough, shortness of breath, generalized malaise, fever after being diagnosed with Covid approximately 7 days ago.  Patient reports that today she feels much worse.  She reports being vaccinated.  Denies any exacerbating or alleviating symptoms.
Some arm soreness; Diarrhea; Vomiting; Chills; A little bit tired; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Some arm soreness), DIARRHOEA (Diarrhea), VOMITING (Vomiting), CHILLS (Chills) and FATIGUE (A little bit tired) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, the patient experienced PAIN IN EXTREMITY (Some arm soreness), DIARRHOEA (Diarrhea), VOMITING (Vomiting), CHILLS (Chills) and FATIGUE (A little bit tired). At the time of the report, PAIN IN EXTREMITY (Some arm soreness), DIARRHOEA (Diarrhea), VOMITING (Vomiting) and CHILLS (Chills) was resolving and FATIGUE (A little bit tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was reported.
had COVID; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (had COVID) in a 27-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Graves' disease ( data logger showed elevated heart rate back to oct2020 which is symptom of Grave's disease.) since 2021.   In April 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Jan-2022, the patient experienced COVID-19 (had COVID). At the time of the report, COVID-19 (had COVID) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Jan-2022, SARS-CoV-2 antibody test: positive (Positive) positive.         No concomitant medications were reported. Prior to the second dose of Moderna vaccine patient was diagnosed with Grave's disease and patient's mother reported that no healthcare professional said it was related to the vaccine because patient's data logger showed he had elevated heart rate dating back to OCT-2020 which is a symptom of Grave's disease. He has not received his booster. No treatment medications were reported.  Company Comment: This spontaneous case concerns a 27-year-old, male patient with no relevant medical history reported, who experienced the unexpected non-serious AESI event of Covid-19 which occurred unspecified days after receiving second dose of mRNA-1273 vaccine administration. SARS-CoV-2 antibody test: positive as on 08-Jan-2022. It was reported that prior to the second dose of Moderna vaccine patient was diagnosed with Grave's disease. Ongoing pandemia remains as a confounder. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.   This case was linked to MOD-2022-495548 (Patient Link).; Sender's Comments: This spontaneous case concerns a 27-year-old, male patient with no relevant medical history reported, who experienced the unexpected non-serious AESI event of Covid-19 which occurred unspecified days after receiving second dose of mRNA-1273 vaccine administration. SARS-CoV-2 antibody test: positive as on 08-Jan-2022. It was reported that prior to the second dose of Moderna vaccine patient was diagnosed with Grave's disease. Ongoing pandemia remains as a confounder. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.
Information has been received from a pharmacist concerning a patient who was vaccinated with a dose of measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3). At an unspecified date a MMR titer for rubella come back negative for the adult patient. The pharmacist believes the patient was vaccinated as a child. The patient sought medical attention via a doctors visit. A product quality complaint was not involved. Additional information has been requested.
Days later after the first dose my arms started to hurt and lasted over night and woken up with hands swollen a few days later my legs started to feel restless, weak, tingly, anxious and they were hurting bad. It last over two weeks
-moderately severe heart/chest pain -painful breathing  Currently trying to rest, took ibuprofen
Moderate heart attack; A spontaneous report  was received from a consumer concerning a male patient of an unspecified age, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced moderate heart attack/myocardial infarction.   The patient's medical history was not provided. Concomitant medications were not provided.  On 03 Feb 2021, prior to the onset of the events, the patient received their first of the two planned doses of mRNA-1273 (Batch number: unknown) for prophylaxis of COVID-19 infection.   On 28 Feb 2021, the patient experienced a moderate heart attack  On 03 Mar 2021, the patient received their second of the two planned doses of mRNA-1273 (Batch number: unknown) for prophylaxis of COVID-19 infection.   The event, moderate heart attack, was deemed medically significant.  Treatment information was not provided. Lab tests were not provided.  Action taken with mRNA-1273 in response to the event was not applicable as patient took both doses of the vaccine.  The outcome of the event, moderate heart attack, was considered resolved as of 28 Feb 2021.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded. Further information has been requested.
BOOSTRIX six years ago / recently been experiencing whooping cough'/suspected vaccination failure; experiencing whooping cough / doctors think she has whooping cough/ suspected Whooping cough; vomiting; Vaccine exposure during pregnancy; This retrospective pregnancy case was reported by a consumer via call center representative and described the occurrence of vaccination failure in an adult female patient who received DTPa (Reduced antigen) (BOOSTRIX) for prophylaxis.   On an unknown date, the patient received BOOSTRIX. The patient's last menstrual period was on an unknown date and estimated date of delivery was on an unknown date. The patient received BOOSTRIX at an unknown time during the pregnancy. On an unknown date, more than 2 years after receiving BOOSTRIX, the patient experienced vaccination failure (serious criteria GSK medically significant), whooping cough (serious criteria GSK medically significant), and vomiting and vaccine exposure during pregnancy. On an unknown date, the outcome of the vaccination failure and vaccine exposure during pregnancy were unknown and the outcome of the whooping cough and vomiting were not recovered/not resolved. The pregnancy outcome was unknown.   It was unknown if the reporter considered the vaccination failure, whooping cough and vomiting to be related to BOOSTRIX.  Additional details were reported as follows: The reporter was patient's friend. The patient's age at vaccination was not reported. The patient received BOOSTRIX during her pregnancy six years ago which leads to vaccine exposure during pregnancy.  The patient had recently been experiencing whooping cough fits with vomiting and had been to the emergency room and to the physician's office several times. The physician thought that patient had whooping cough. The patient had a test to confirm whether or not it was whooping cough but the test results were unknown at the time of reporting. This case was considered as suspected vaccination failure as details regarding vaccination schedule and laboratory confirmation were unknown at the time of reporting. Sender's Comments:  US-GLAXOSMITHKLINE-US2020AMR229111: same reporter
About 8 hours after the third (booster) dose, malaise and low-grade fever began.  Temperature reached 100.1 degrees the next morning and persisted in that range for a day or two,  Over the subsequent eight weeks, low-grade fever has recurred almost daily, with temperatures in the 99.0-99.9 F range.  When temperature is elevated, associated symptoms are fatigue, malaise, weakness, loss of appetite, and rapid fluctuation between feeling hot and feeling cold.  These periods alternate with periods of normal temperature with resolution of the symptoms, except for mild persistent weakness and malaise.  Weight has decreased by less than five pounds, related to the decreased appetite.
Severe chills, sweating, low grade fever, nausea, dizziness,  headache
Rash behind ear started on 04/01/2021, then spread chest, my groin, my waist and my hands, but not where I received the shot. No discharge or drainage, just red raised flat bumps, and it itched very bad. Took Zyrtec, and Pepcid and the symptoms did go away.
No additional AE; temperature excursion in which PROQUAD and V ARlV AX may have been administered to patient(s).; This spontaneous report as received from a nurse and refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 06-APR-2021, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck)(VARIVAX) lot # T024284, expiration date: 15-JUL-2022, dose 1 (formulation, strength, exact dose, frequency, route of administration were not reported) for prophylaxis. On an unknown date, the dose of the vaccine was exposed to temperature excursion at 17.32 Fahrenheit degrees (F) for 1 hour 22 minutes. There was no previous temperature excursion reported. The call was due to digital data logger. No additional adverse event was reported.
I believe I experienced multiple symptoms as a result of my vaccine. My experience matches exactly as described in the article.  ON 4/1/21 at approximately 4pm I awoke from a nap experiencing acute vertigo, nausea and headache. I also was experiencing fever and chills. I began treating with excedrine but did not have an effect. The vertigo was very acute, my eyes were skipping and I was unable to walk. Nause was so intense that any attempt to leave my bed resulted in vomiting. I was unable to eat and could barely drink for the first 24 hours. Friday 4/2 at approx 7pm I took a dose of Promethazine which began to help the nausea. Extreme headache/migraine lasted for 3 days. During this time I also experienced extreme neck pain, as well as pain near base of skull, behind my ears, and on my temples. Symptoms were steadily improving each day, so I did not seek medical care during this time. I feel I became fully recovered by 4/18. I just had my second vaccine dose on 4/21 and I am very nervous about experiencing a relapse of symptoms.
Information has been received from a Doctor of Pharmacy and a Pharm D. student concerning an 89 year old male with no known drug allergies who on 24-APR-2007 was hospitalized for a cerebrovascular accident. On the morning he was admitted to the hospital, the patient was given intravenous immune globulin. During the evening of 24-APR-2007, the patient was vaccinated intramuscularly in the left arm with a dose of Pneumovax 23. The patient's left arm became very hot, red, and very swollen. By the next day, the swelling traveled down the arm. The Pharm D. stated that the physician thought the patient may have had a "hyper immune response". The patient was discharged from the hospital on 29-APR-2007 and was considered recovered. Additional information has been requested.
PT HAD A SYNCOPAL EPISODE 5 MIN AFTER VACCINE GIVEN. NO WARNING. NO HX OF SYNCOPE IN PAST. LOC FOR 5 SECS. HIT BACK OF HEAD. PT PALE AND DIAPHORETIC. PT WAS STANDING IN A COOL ROOM. SENT TO ER BECAUSE OF HEAD INJURY TO BACK OF HEAD.
After receiving the Pfizer covid-19 vaccine. During the 15 minutes waiting, patient's father took pt to the front of the store to buy ice cream. While he was paying the ice cream, pt fainted and hit head on the register counter.  Ambulance was called. Store personnel and pharmacist check up on pt. She said she was feeling fine. No sign of short of breath or allergic reaction. Emergency personnel arrived and performed check up on pt. Pt stated she was fine and refused the ambulance or the trip to hospital for check up. Pt's dad sign waiver and release with emergency personnel and left store with pt.